The role of C6orf223 and NSUN5P1 in cancer has not yet been reported, but many studies have shown that SNHG4 is involved in multiple cancers, including osteosarcoma [19], prostate cancer [20], and cervical cancer [21]. Here, SNHG4 is linked to prostate cancer.